Breachway Investments’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$616K Sell
513
-95
-16% -$97.1K 0.93% 36
2026
Q1
$580K Buy
608
+1
+0.2% +$1.01K 0.56% 39
2025
Q4
$652K Buy
+607
New +$580K 0.69% 38

Other funds holding LLY

Breachway Investments's LLY Position: Q2 2026 in Review

Breachway Investments reduced its Eli Lilly (LLY) stake by 16% in Q2 2026, selling an estimated $97.1K and leaving 513 shares worth $616K. The position accounts for 0.93% of the portfolio, ranked #36.

Breachway Investments first reported a position in LLY in Q4 2025 and has held it in 3 quarters since. The position peaked at $652K in Q4 2025. 3,039 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Breachway Investments held 513 shares of Eli Lilly worth $616K as of Q2 2026.
  • Breachway Investments sold 95 Eli Lilly shares in Q2 2026, an estimated $97.1K.
  • Eli Lilly made up 0.93% of Breachway Investments's portfolio in Q2 2026, its #36 holding.
  • Breachway Investments first reported a position in Eli Lilly in Q4 2025 and has held it in 3 quarters since.
  • Breachway Investments's Eli Lilly position peaked at $652K in Q4 2025.
  • 3,039 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Breachway Investments's 13F filing for Q2 2026, filed 13 Jul 2026.